W
TGTX icon

Wealthfront’s TG Therapeutics TGTX Stock Holding History

Wealthfront’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1
Closed – – 973
2015
Q3 		$0 Buy
+1
New +$15 ﹤0.01% 1427

Other funds holding TGTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wealthfront's TGTX Position: Q4 2015 in Review

Wealthfront sold out of TG Therapeutics (TGTX) in Q4 2015, closing a stake of 1 share.

Wealthfront first reported a position in TGTX in Q3 2015 and held it in 1 quarter. The position peaked at $0 in Q3 2015. 87 funds tracked by Wall St. Rank hold TGTX as of Q4 2015.

  • Wealthfront reported no remaining TG Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Wealthfront sold 1 TG Therapeutics share in Q4 2015.
  • Wealthfront first reported a position in TG Therapeutics in Q3 2015 and held it in 1 quarter.
  • Wealthfront's TG Therapeutics position peaked at $0 in Q3 2015.
  • 87 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2015.

Based on Wealthfront's 13F filing for Q4 2015, filed 17 Feb 2016.